Halozyme Therapeutics Inc. HALO
NAS: HALO | ISIN: US40637H1095 10/07/2025
57,63 USD (+1,86%)
(+1,86%)
10/07/2025
Profiel Halozyme Therapeutics Inc.
Website: www.halozyme.com
Hoofdzetel: San Diego, California Verenigde Staten
CEO: Helen Torley
Werknemers: 452